Xinhua Shu

Dr. Xinhua Shu is a Reader (equivalent to Associate Professor) in Biological and Biomedical Sciences at Glasgow Caledonian University. With an h-index of 33 and 4016 citations from 118 research outputs, Dr. Shu maintains an active and impactful research program spanning molecular biology, neuroscience, and translational medicine.

Dr. Shu's research focuses on:

• Zebrafish models for disease research (100% focus)
• Retinal pigment Epithelium (81% focus)
• Age-related Macular Degeneration (78% focus)
• Retinitis pigmentosa (78% focus)
• Photoreceptor Cell biology (70% focus)
• TSPO ligands and their therapeutic applications

Recent research trends show Dr. Shu expanding into Alzheimer's disease research through TSPO ligands while maintaining strong work in retinal biology and degeneration. The research employs diverse methodologies including zebrafish models, molecular biology techniques, and polyomics approaches to address fundamental questions in neurodegeneration and retinal diseases.

Notable scientific contributions include:

• Development of therapy for age-related macular degeneration
• Evaluating protective effects of TSPO ligands in Alzheimer's disease mouse models
• Research on domoic acid toxicity in the retina
• Investigations into Xuebijing's molecular mechanisms against sepsis

Dr. Shu has secured research funding from organizations including the Scottish Funding Council and maintains an active presence in the academic community through invited talks and collaborations. With 20 recorded academic activities and supervision of multiple students, Dr. Shu contributes significantly to both research and academic training in biomedical sciences.